Latest Us Market News

Tetratherix reports encouraging safety and stability results from its Tutelix hydrogel spacer trial, initiates stage 2 recruitment, and secures a $3.3 million government grant to boost manufacturing capacity and R&D.

Tourism Holdings Limited (thl) reported a challenging FY25 with a significant profit decline but is confident in a growth rebound supported by international tourism recovery and strategic initiatives.

Omnia Metals Group has raised $1.58 million through a share placement to accelerate exploration in Western Australia and pursue rare earth and precious metals acquisitions in the United States.

HyTerra Limited has begun trading on the US OTCQB Venture Market, opening doors to American investors and supporting its strategic expansion in the burgeoning geologic hydrogen sector.

Great Northern Minerals has secured full ownership of the Catalyst Ridge Project in California’s Mountain Pass District, initiating exploration backed by a $2.6 million capital raise and strategic US appointments.

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

Resolution Minerals is fast-tracking its downstream antimony strategy in Idaho, aiming to become a key US supplier while preparing for a Nasdaq listing with Tribeca Capital's support.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Eden Innovations reports a surge in US orders and quotations for its OptiBlend dual fuel kits, driven by growing demand from data centres. Recent sales exceed US$300k, with a robust pipeline of US$4.4 million signalling strong market momentum.

Cettire reports a 3% dip in sales revenue for Q1 FY26 but posts a $10 million quarterly EBITDA improvement, driven by strong growth outside the US. The luxury e-commerce platform is navigating a challenging market with a focus on profitability and geographic diversification.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.